Home | Welcome to Contract Pharma   
Last Updated Thursday, May 23 2013
Print RSS Feed

Breaking News

Related Searches: Financial Reports •
Financial Report: Roche 1Q

April 16, 2009
Pharmaceutical revenues were flat at $8.1 billion (up 8% in local currencies) with Europe/ROW sales down 8%, U.S. sales up 1%, and Japan sales up 58%.  Read More »
Cangene Signs VIG Supply Pact with DoD

April 16, 2009
The Chemical Biological Medical Systems Project Management Office of the U.S. Department of Defense (DoD) has signed a four-year agreement with Cangene Corp. to purchase its Vaccinia Immune Globulin Intravenous (Human) (VIG) for use by U.S. military perso  Read More »
Norwich Pharmaceuticals

April 16, 2009
Dan Casey has been appointed vice president business development, and Dale A. Dyer was named director of business development at Norwich Pharmaceuticals.  Read More »
Roche, Genentech Organize Leadership Roles

April 15, 2009
Following the completion of the Genentech transaction, Roche has made organizational structure changes and filled key management positions that will become effective May 1, 2009.  Read More »
Sanofi To Acquire BiPar Sciences

April 15, 2009
Sanofi-aventis has entered an agreement to acquire BiPar Sciences, Inc., a privately held U.S. biopharmaceutical company developing tumor-selective approaches for the treatment of cancer, for as much as $500 million.  Read More »
Financial Report: Abbott 1Q

April 15, 2009
Worldwide pharmaceutical sales were $3.6 billion (-6%). Humira sales were $1.0 billion (+17%).  Read More »
Cangene

April 15, 2009
Paul Brisebois has been named vice president, sales, marketing and business development, Cangene Corp. Mr. Brisebois replaces John McMillan, who retired last year.  Read More »
Bridge Laboratories

April 15, 2009
Haijun (Lou) Dong, Ph.D., MBA has been appointed general manager at Bridge Laboratories' Beijing, China, facility.   Read More »
Financial Report: Johnson & Johnson 1Q

April 14, 2009
Worldwide pharmaceutical sales were $5.8 billion in the quarter (-10%) with an operational decline of 5% and a negative impact from currency of 5%. Domestic sales were down 10%.  Read More »
Oxygen Biotherapeutics, Hospira Sign Oxycyte Supply Pact

April 14, 2009
Oxygen Biotherapeutics, Inc. has reached a development and commercial supply agreement with Hospira's One 2 One Global Pharmaceutical Services business unit to manufacture clinical-grade Oxycyte, a perfluorocarbon (PFC) therapeutic oxygen carrier.   Read More »
GVK Biosciences, Excel Form Asia Alliance

April 14, 2009
GVK Biosciences, a research services provider, has entered into a strategic alliance with Excel PharmaStudies, a Chinese CRO, to conduct clinical trials in Asia.   Read More »
Mylan

April 13, 2009
Merrill Lynch vet Cuneo named CFO at Mylan  Read More »
PharmEng Restructures

April 13, 2009
PharmEng International Inc. has decided to reduce corporate costs as part of its ongoing restructuring efforts.  Read More »
Genentech Withdraws Raptiva from U.S. Market

April 9, 2009
Genentech will voluntary withdraw the psoriasis drug Raptiva (efalizumab) from the U.S. market due to the association with an increased risk of progressive multifocal leukoencephalopathy (PML), a rare and usually fatal CNS disease.  Read More »
Confab Facilities Successfully Inspected

April 9, 2009
Following a GMP inspection of Confab Laboratories’ facilities, systems, and procedures, the FDA has classified the facility as acceptable. No objectionable items where issued.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: